Citations 3
Long-term efficacy of pembrolizumab (pembro; MK-3475) in a pooled analysis of 655 patients (pts) with advanced melanoma (MEL) enrolled in KEYNOTE-001.
Hodi, F. Stephen , Hwu, Wen‐Jen , Gangadhar, Tara C., Dronca, Roxana , Patnaik, Amita , Zarour, Hassane M. , Kefford, Richard , Lindia, Jill A., Li, Xiaoyun , Ebbinghaus, Scot, Kang, Soonmo Peter, Hamid, Omid , Daud, Adil , Ribas, Antoni , Robert, Caroline , Wolchok, Jedd D. , Joshua, Anthony M. , Weber, Jeffrey S. , Joseph, Richard W.
Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 9005-9005
Model-based analysis of the relationship between pembrolizumab (MK-3475) exposure and efficacy in patients with advanced or metastatic melanoma.
Gangadhar, Tara C., Hamid, Omid , Dummer, Reinhard , Mehnert, Janice M. , Celentano, Kellie Ann, Lindia, Jill A., Chatterjee, Manash , Turner, David C. , Mayawala, Kapil , Elassaiss‐Schaap, Jeroen , Alwis, Dinesh P. de, Li, Xiaoyun , Ebbinghaus, Scot, Kang, Soonmo Peter, Kefford, Richard , Joseph, Richard W. , Puzanov, Igor , Robert, Caroline , Ribas, Antoni , Daud, Adil
Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3068-3068
Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma
Ribas, Antoni , Hamid, Omid , Daud, Adil , Hodi, F. Stephen , Kefford, Richard , Joshua, Anthony M. , Patnaik, Amita , Hwu, Wen-Jen , Weber, Jeffrey S. , Gangadhar, Tara C., Hersey, Peter , Dronca, Roxana , Joseph, Richard W. , Zarour, Hassane M. , Lawrence, Donald P. , Algazi, Alain P. , Rizvi, Naiyer A. , Hoffner, Brianna, Mateus, Christine , Gergich, Kevin, Lindia, Jill A., Giannotti, Maxine, Li, Xiaoyun , Ebbinghaus, Scot, Kang, Soonmo Peter, Robert, Caroline , Wolchok, Jedd D. , Hwu, Wen‐Jen , Chmielowski, Bartosz , Daud, Adil I , Weber, Jeffrey
JAMA | April 19, 2016 | Volume: 315 | Issue: 15 | Pages: 1600